Common TitleELECTRON: Arms 1-8
Official Title Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Phase Phase II
ClinicalTrials.gov NCT01260350
Treatments
Sofosbuvir
Sofosbuvir
Tradename:SovaldiOther Names:SOFClass:FDA-ApprovedFunding
IndustryGilead Sciences